Immunotherapy of ovarian cancer with a monoclonal antibody specific for the extracellular domain of anti-Müllerian hormone receptor II

Epithelial ovarian carcinoma (EOC) is the most prevalent and lethal form of ovarian cancer. The low five-year overall survival after EOC diagnosis indicates an urgent need for more effective ways to control this disease. Anti-Müllerian hormone receptor 2 (AMHR2) is an ovarian protein overexpressed i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Mazumder, Suparna, Swank, Valerie, Komar, Anton A., Johnson, Justin M., Tuohy, Vincent K.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2020
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7244012/
https://ncbi.nlm.nih.gov/pubmed/32499873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27585
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars